RECRUITING

Exercise and Movement to Enhance Resiliency in Cancer Patients

Talk to us

Conditions

Gynecologic CancerPhysical Activity

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.

Official Title

EMPOWER: Exercise and Movement to Promote Our Patients With (Gynecologic) Cancer to Enhance Resiliency

Quick Facts

Study Start:2025-03-24
Study Completion:2031-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06809933

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18 years or older.
  2. 2. Newly diagnosed with a gynecological cancer (including ovarian tubal or peritoneal, uterine, cervical, vaginal, vulvar, and/or gestational trophoblastic neoplasia) and currently undergoing treatment chemotherapy, surgery, etc.).
  3. 3. Able to understand study procedures and to comply with them for the entire length of the study.
  4. 4. Ability to understand a written informed consent document, and the willingness to sign it.
  5. 5. Eastern Cooperative Oncology Group (ECOG) status \< 4.
  6. 6. Willingness to participate and wear an activity tracker (e.g., Move wearable or equivalent).
  7. 7. Planning to start systemic treatment or currently receiving Cycle 1 of systemic treatment.
  1. 1. Medically ineligible or contraindications to exercise as determined by their oncologist; or contradiction to any other study-related procedure or assessment.
  2. 2. Cognitive or visual impairments that would limit participant's ability to utilize and interact with the DHT platform.
  3. 3. Existing performance of excessive physical activity (\>210 minutes per week of moderate to vigorous intensity exercise at baseline).
  4. 4. Existing enrollment in an exercise program or physical therapy program.
  5. 5. Inability to speak and read English.

Contacts and Locations

Study Contact

Nathalie Halley
CONTACT
877-827-3222
EMPOWER@ucsf.edu

Principal Investigator

Stephanie Cham, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, San Francisco
San Francisco, California, 94143
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Stephanie Cham, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-24
Study Completion Date2031-08-31

Study Record Updates

Study Start Date2025-03-24
Study Completion Date2031-08-31

Terms related to this study

Keywords Provided by Researchers

  • Physical Activity

Additional Relevant MeSH Terms

  • Gynecologic Cancer